secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001437749-25-021383
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals added to Russell 2000 and Russell 3000 Indexes
-------------------------------------------------------------------

- Effective after market close June 27, 2025 as part of 2025 annual reconstitution.
- CEO Sean Brynjelsen called it a significant milestone recognizing shareholder value.
- Addition expands visibility among index fund managers and institutional investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000143774925021383/0001437749-25-021383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000143774925021383/eton20250625_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer